Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients (Q37016967)

From Wikidata
Jump to navigation Jump to search
scientific article published on December 2007
edit
Language Label Description Also known as
English
Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients
scientific article published on December 2007

    Statements

    Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients (English)
    0 references
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit